Hrt Financial LP Standard Biotools Inc. Transaction History

Hrt Financial LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$1.87 - $2.78 $948,869 - $1.41 Million	507,417 New	507,417 $1.38 Million
Q2 2023 Aug 11, 2023	BUY	$1.47 - $2.56 $17,459 - $30,405	11,877 New	11,877 $22,000
Q1 2022 May 16, 2022	SELL	$2.8 - $3.96 $119,722 - $169,321	-42,758 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$3.63 - $6.13 $326 - $551	-90 Reduced 0.21%	42,758 $167,000
Q3 2021 Nov 15, 2021	BUY	$5.5 - $7.41 $235,664 - $317,503	42,848 New	42,848 $282,000
Q2 2021 Aug 16, 2021	SELL	$4.35 - $6.35 $46,231 - $67,487	-10,628 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$3.94 - $7.09 $408,451 - $735,006	-103,668 Reduced 90.7%	10,628 $48,000
Q4 2020 Feb 16, 2021	BUY	$5.45 - $8.65 $622,913 - $988,660	114,296 New	114,296 $685,000
Q4 2019 Feb 14, 2020	SELL	$2.3 - $5.12 $41,880 - $93,230	-18,209 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$4.63 - $12.15 $84,307 - $221,239	18,209 New	18,209 $84,000

143

279M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $132M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.